About Us

Welcome to Thrombosis Adviser... your global thrombosis hub

This section introduces our vision for Thrombosis Adviser and provides an overview of all the contributors and their roles

In this section:

Your thrombosis hub

  • The field of thrombosis is exciting and fast moving, but keeping up-to-date with the vast number of studies and technological advances across all aspects of thrombosis is a challenge for us all
  • With Thrombosis Adviser, we aim to improve the understanding and management of thromboembolic disorders by becoming a global thrombosis hub that provides trustworthy, balanced educational materials for all our readers
  • You can access key information quickly through short, focussed articles and dynamic content, such as video clips and animations, or visit the ‘Knowledge Base’ for more detailed therapy area content
  • Information can be viewed and shared easily, whichever platform you favour
  • We hope that in this ever-changing environment you find Thrombosis Adviser informative and inspiring. Share you experiences with colleagues and friends using the social icons below

Meet the Steering Committee

  • Thrombosis Adviser is developed in collaboration with a Steering Committee who are experts in the field of thrombosis
  • The Steering Committee is dedicated to fostering awareness and understanding about new approaches in the prevention, diagnosis and treatment of thromboembolic diseases

Emeritus Professor Sylvia Haas, MD
Emeritus Professor Sylvia Haas, MD
  • Emeritus Professor of Medicine; Director of the Haemostasis and Thrombosis Research Group at the Institute for Experimental Oncology and Therapy Research, Technical University of Munich, Germany
  • Scientific focus: development of new antithrombotic therapies, laboratory monitoring of anticoagulants, biomarkers and tumour-associated thrombosis
  • Member or fellow of several international professional societies, including the International Society on Thrombosis and Haemostasis (ISTH) and the International Society of Angiology (ISA); member of the editorial board of several peer-reviewed journals including Current Haematology Reports, International Journal of Angiology and Clinical and Applied Thrombosis and Haemostasis
Professor Gregory YH Lip, MD
Professor Gregory YH Lip, MD
  • Professor of Cardiovascular Medicine and lead of a multidisciplinary research group at the Centre for Cardiovascular Sciences, University of Birmingham, UK
  • Scientific focus: epidemiology and thromboembolic pathophysiology of AF; clinical risk stratification, including development of the CHA2DS2-VASc and HAS-BLED scores
  • Included in the Thomson Reuters ScienceWatch list of the World’s Most Influential Scientific Minds in 2014 and ranked by Expertscape as one of the world’s leading experts in the understanding and treatment of AF
  • Board member of the European Heart Rhythm Association (EHRA) and the European Society of Cardiology (ESC) Acute Cardiac Care Association; involved in the development of guidelines for the American College of Chest Physicians (ACCP), EHRA and ESC; has acted as senior editor for major international textbooks and medical journals
Professor Alexander GG Turpie, MD
Professor Alexander GG Turpie, MD
  • Emeritus Professor of Medicine at McMaster University, Hamilton, Ontario, Canada
  • Scientific focus: new antithrombotic drugs for the management of venous and arterial thrombosis and anticoagulant therapy in patients with prosthetic heart valves
  • Served on numerous professional and university-related committees and is a frequent lecturer at professional meetings worldwide
  • Authored more than 700 published articles, abstracts, book chapters and books; reviewer for many journals including Annals of Internal Medicine, Circulation, The Lancet and The New England Journal of Medicine; and serves on the editorial boards of Vascular Medicine Review and HeartDrug
Professor the Lord Ajay K Kakkar, MBBS (Hons), BSc, PhD, FRCS, FRCP
Professor the Lord Ajay K Kakkar, MBBS (Hons), BSc, PhD, FRCS, FRCP
  • Professor of Surgery at University College London; Consultant Surgeon at University College London Hospital; Director of the Thrombosis Research Institute (TRI), London, UK
  • Scientific focus: prevention and treatment of venous and arterial thromboembolic disease
  • Actively involved with several professional and academic committees and is frequently invited to lecture at both national and international meetings
  • Involved in numerous international studies and registries investigating the prevention and management of venous thromboembolic disease, cancer-associated thrombosis and AF

What is the role of the Steering Committee?

  • To advise on relevant core topics for the website, based on their clinical expertise
  • To identify updates and new topics of clinical interest for the website, and approve any proposals for changing functionality or content
  • To oversee the development of content, sanction it for final inclusion and provide overall direction and oversight, ensuring the independence and clinical relevance of the website

Up-to-date content you can rely on

The content for Thrombosis Adviser is assessed on an ongoing basis to provide up-to-date, relevant information

  • A daily literature review is undertaken using validated scientific search criteria and the PubMed database to search for new publications under each key topic relevant to the website
  • The results are reviewed for relevance based on pre-defined inclusion criteria, as agreed by the Steering Committee
  • Guideline recommendations from internationally recognized bodies and data from randomized controlled clinical trials are prioritized when selecting new topics and updating existing content for the website

What else do you need to know?

The role of the sponsor (Bayer Pharma AG)

  • The sponsor provides financial support for the website, and reviews content to ensure accuracy of information in compliance with established pharmaceutical codes of practice

The role of the medial writing agency (Chameleon Communications International)

  • Suitably qualified individuals at the agency conduct the literature reviews described in the ‘Up-to-date content you can rely on’ section and screen the results using criteria defined and reviewed by the Steering Committee
  • The agency generates website content and updates, based solely on the direction of the Steering Committee, and co-ordinates meetings and discussions involving the Steering Committee and sponsor

Where to next?

Antithrombotics Weekly

Follow the weekly updates from Emeritus Professor Sylvia Haas MD

View

Sign up to our Thrombosis Adviser Newsletter

Receive regular news from experts in the area of thrombosis

Sign up

Join the conversation

Thrombosis Connection

Thrombosis Connection, A Healthcare Professionals’ Forum welcomes individuals interested in sharing, developing and fostering innovative solutions in the field of thrombosis.

Join LinkedIn Group